Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article by Nasdaq cited a study published in a supplement of The American Journal of Managed Care® (AJMC®) titled “The Economic Impact of Peanut Allergies.” The study indicated that peanut allergies affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population. The article noted that these patients could benefit from Aimmune Therapeutics’ treatment Palforzia, the first FDA-approved treatment for patients with peanut allergy.
A press release from UrgentMED Network, “UrgentMED Network Now Offering Telemedicine and Coronavirus Evaluations and Testing at Select Locations,” referenced a study published in the February 2015 issue of AJMC®. The study, “Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs,” highlighted that successful patient engagement in a nationally available, remotely delivered behavioral health intervention can significantly improve medical outcomes and lower healthcare costs.
An article from AJMC®’s sister site, The Center for Biosimilars®, was featured in the April 15, 2020, daily Regulatory Recon news and intelligence briefing from Regulatory Focus. The article, “Merck Follows Rivals With US Launch of Trastuzumab Biosimilar,” was included in the In Focus: US section of the briefing and noted how Merck’s trastuzumab biosimilar Ontruzant marks the fifth trastuzumab biosimilar available on the US market.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More